Cargando…

Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy

In many organisms, antimicrobial peptides (AMPs) display wide activities in innate host defense against microbial pathogens. Mammalian AMPs include the cathelicidin and defensin families. LL37 is the only one member of the cathelicidin family of host defense peptides expressed in humans. Since its d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Fatai, Zhu, Yingkang, Zhang, Guodong, Liu, Zunpeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445486/ https://www.ncbi.nlm.nih.gov/pubmed/36081952 http://dx.doi.org/10.3389/fphar.2022.944147

Ejemplares similares

The human cathelicidin peptide LL-37 inhibits pancreatic cancer growth by suppressing autophagy and reprogramming of the tumor immune microenvironment
por: Zhang, Zhu, et al.
Publicado: (2022)

Antibacterial and Anti-Inflammatory Properties of a Novel Antimicrobial Peptide Derived from LL-37
por: Zhuo, Haiwei, et al.
Publicado: (2022)

Novel Hybrid Peptide Cecropin A (1–8)-LL37 (17–30) with Potential Antibacterial Activity
por: Wei, Xu-Biao, et al.
Publicado: (2016)

Molecular Dynamics Simulations of Human Antimicrobial Peptide LL-37 in Model POPC and POPG Lipid Bilayers
por: Zhao, Liling, et al.
Publicado: (2018)

Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37
por: Mücke, Pierre-Alexander, et al.
Publicado: (2020)

The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent
por: Ridyard, Kylen E., et al.
Publicado: (2021)

CXCR2 specific endocytosis of immunomodulatory peptide LL-37 in human monocytes and formation of LL-37 positive large vesicles in differentiated monoosteophils
por: Zhang, Zhifang, et al.
Publicado: (2019)

Influence of Lipidation Pattern of the KR12 Fragment of Peptide LL-37 on Its Antibacterial and Hemolytic Activities
por: Kamysz, Elżbieta, et al.
Publicado: (2023)

Studies on citrullinated LL-37: detection in human airways, antibacterial effects and biophysical properties
por: Al-Adwani, Salma, et al.
Publicado: (2020)

Spotlight on Human LL-37, an Immunomodulatory Peptide with Promising Cell-Penetrating Properties
por: Seil, Michèle, et al.
Publicado: (2010)

The Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer Drugs
por: Kuroda, Kengo, et al.
Publicado: (2015)

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
por: Babikir, Ibrahim H., et al.
Publicado: (2018)

Oxidative stress induced in E. coli by the human antimicrobial peptide LL-37
por: Choi, Heejun, et al.
Publicado: (2017)

Antibacterial and osteogenesis performances of LL37-loaded titania nanopores in vitro and in vivo
por: Shen, Xinkun, et al.
Publicado: (2019)

Escherichia Coli PagP Enzyme-Based De Novo Design and In Vitro Activity of Antibacterial Peptide LL-37
por: Yang, Hao, et al.
Publicado: (2017)

SP-LL-37, human antimicrobial peptide, enhances disease resistance in transgenic rice
por: Lee, In Hye, et al.
Publicado: (2017)

Renovation of the Globe of Science and Innovation
por: Balle, Christoph
Publicado: (2016)

Antimicrobial peptide LL-37 participates in the transcriptional regulation of melanoma cells
por: Muñoz, Mindy, et al.
Publicado: (2016)

Antimicrobial peptide LL-37 is bactericidal against Staphylococcus aureus biofilms
por: Kang, Jason, et al.
Publicado: (2019)

LL-37, a Multi-Faceted Amphipathic Peptide Involved in NETosis
por: Radic, Marko, et al.
Publicado: (2022)

Antimicrobial Peptide Loss, Except for LL-37, is not Characteristic of Atopic Dermatitis
por: SZABÓ, Lilla, et al.
Publicado: (2023)

Rigidification of the Escherichia coli cytoplasm by the human antimicrobial peptide LL-37 revealed by superresolution fluorescence microscopy
por: Zhu, Yanyu, et al.
Publicado: (2019)

LL-37 Triggers Antimicrobial Activity in Human Platelets
por: Sánchez-Peña, Francisco Javier, et al.
Publicado: (2023)

The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected Wounds
por: Duplantier, Allen J., et al.
Publicado: (2013)

The Human Antimicrobial Peptides Dermcidin and LL-37 Show Novel Distinct Pathways in Membrane Interactions
por: Zeth, Kornelius, et al.
Publicado: (2017)

The Human LL-37(17-29) antimicrobial peptide reveals a functional supramolecular structure
por: Engelberg, Yizhaq, et al.
Publicado: (2020)

Long-Lasting Stable Expression of Human LL-37 Antimicrobial Peptide in Transgenic Barley Plants
por: Mirzaee, Malihe, et al.
Publicado: (2021)

Design, synthesis, and characterization of non-hemolytic antimicrobial peptides related to human cathelicidin LL-37
por: Krishnamoorthy, Rajavenkatesh, et al.
Publicado: (2023)

Human host defence peptide LL37 and anti-cyclic citrullinated peptide antibody in early inflammatory arthritis
por: Hitchon, Carol A, et al.
Publicado: (2019)

Significance of LL-37 on Immunomodulation and Disease Outcome
por: Yang, Binbin, et al.
Publicado: (2020)

Cathelicidin LL-37: An Antimicrobial Peptide with a Role in Inflammatory Skin Disease
por: Reinholz, Markus, et al.
Publicado: (2012)

Salivary concentration of the antimicrobial peptide LL-37 in patients with oral lichen planus
por: Davidopoulou, Sotiria, et al.
Publicado: (2014)

Significance and Diagnostic Role of Antimicrobial Cathelicidins (LL-37) Peptides in Oral Health
por: Khurshid, Zohaib, et al.
Publicado: (2017)

Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy
por: Findlay, Emily Gwyer, et al.
Publicado: (2019)

Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections
por: Pahar, Bapi, et al.
Publicado: (2020)

In Vitro Antifungal Activity of LL-37 Analogue Peptides against Candida spp.
por: Pinilla, Gladys, et al.
Publicado: (2022)

Renovation works started for the Globe of Innovation
por: Brice, Maximilien
Publicado: (2015)

Generation of Monoclonal Antibodies Specific for Native LL37 and Citrullinated LL37 That Discriminate the Two LL37 Forms in the Skin and Circulation of Cutaneous/Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients
por: Lande, Roberto, et al.
Publicado: (2020)

Comparison of Antibacterial Effect of Cationic Peptide LL‐37 and Cefalexin on Clinical Staphylococcus aureus‐induced Infection after Femur Fracture Fixation
por: Yan, Cheng‐yuan, et al.
Publicado: (2020)

Repurposing of Bromocriptine for Cancer Therapy
por: Seo, Ean-Jeong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r5ru1l4rhvtg6ttbjs0g9saus2